These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12610072)

  • 1. Austronesian-speaking people in Papua New Guinea have susceptibility to obesity and type 2 diabetes.
    Sakaue M; Fuke Y; Katsuyama T; Kawabata M; Taniguchi H
    Diabetes Care; 2003 Mar; 26(3):955-6. PubMed ID: 12610072
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose tolerance in Papua New Guinea: ethnic differences, association with environmental and behavioural factors and the possible emergence of glucose intolerance in a highland community.
    King H; Finch C; Collins A; Koki G; King LF; Heywood P; Zimmet P
    Med J Aust; 1989 Aug; 151(4):204-10. PubMed ID: 2668711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.
    San Millán JL; Cortón M; Villuendas G; Sancho J; Peral B; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2640-6. PubMed ID: 15181035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of study for type 2 diabetes susceptibility genes].
    Osawa H; Onuma H; Makino H
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():271-6. PubMed ID: 12355758
    [No Abstract]   [Full Text] [Related]  

  • 6. Type 2 diabetes mellitus in Papua New Guinea--an historical perspective.
    Ogle GD
    P N G Med J; 2001; 44(3-4):81-7. PubMed ID: 12422977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genomics of type 2 diabetes].
    Hara K; Kadowaki T
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():283-9. PubMed ID: 12355760
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetics of the metabolic syndrome.
    Groop L
    Br J Nutr; 2000 Mar; 83 Suppl 1():S39-48. PubMed ID: 10889791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.
    Muller YL; Bogardus C; Beamer BA; Shuldiner AR; Baier LJ
    Diabetes; 2003 Jul; 52(7):1864-71. PubMed ID: 12829658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic susceptibility of type 2 diabetes].
    Hara K; Kadowaki T
    Seikagaku; 2003 Oct; 75(10):1345-60. PubMed ID: 14635526
    [No Abstract]   [Full Text] [Related]  

  • 11. Searching for type 2 diabetes genes: prospects in pharmacotherapy.
    Sesti G
    Pharmacogenomics J; 2002; 2(1):25-9. PubMed ID: 11990377
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic consequences of the West African diaspora: lessons from the thrifty gene.
    Osei K
    J Lab Clin Med; 1999 Feb; 133(2):98-111. PubMed ID: 9989761
    [No Abstract]   [Full Text] [Related]  

  • 13. The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes.
    Mori H; Ikegami H; Kawaguchi Y; Seino S; Yokoi N; Takeda J; Inoue I; Seino Y; Yasuda K; Hanafusa T; Yamagata K; Awata T; Kadowaki T; Hara K; Yamada N; Gotoda T; Iwasaki N; Iwamoto Y; Sanke T; Nanjo K; Oka Y; Matsutani A; Maeda E; Kasuga M
    Diabetes; 2001 Apr; 50(4):891-4. PubMed ID: 11289058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose tolerance in Papua New Guinea: past and future studies.
    King H
    P N G Med J; 1985 Dec; 28(4):283-9. PubMed ID: 3869762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes.
    Memisoglu A; Hu FB; Hankinson SE; Liu S; Meigs JB; Altshuler DM; Hunter DJ; Manson JE
    Diabetes Care; 2003 Oct; 26(10):2915-7. PubMed ID: 14514601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.
    Douglas JA; Erdos MR; Watanabe RM; Braun A; Johnston CL; Oeth P; Mohlke KL; Valle TT; Ehnholm C; Buchanan TA; Bergman RN; Collins FS; Boehnke M; Tuomilehto J
    Diabetes; 2001 Apr; 50(4):886-90. PubMed ID: 11289057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trends in therapy for diabetes mellitus].
    Kadowaki T
    Masui; 2002 Dec; 51 Suppl():S105-14. PubMed ID: 12655721
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin resistance and obesity.
    Schwartz MW; Kahn SE
    Nature; 1999 Dec 23-30; 402(6764):860-1. PubMed ID: 10622250
    [No Abstract]   [Full Text] [Related]  

  • 19. No difference in serum leptin concentrations between urban-dwelling Austronesians and Non-Austronesians in Papua New Guinea.
    Tanaka M; Umezaki M; Natsuhara K; Yamauchi T; Inaoka T; Hongo T; Nagano M; Watanabe C; Ohtsuka R
    Am J Hum Biol; 2005; 17(6):696-703. PubMed ID: 16254894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perspective for personalized medicine for diabetes].
    Kadowaki T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():729-37. PubMed ID: 12430310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.